Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials (Q40869082)

24 September 2017

1 reference

title

Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials (English)

1 reference

intrauterine growth restriction

24 September 2017

0 references

1 reference

1 reference

1 reference

G A Dekker

1

1 reference

PubMed ID

8420330

24 September 2017

B M Sibai

series ordinal

2

1 reference

PubMed ID

8420330

24 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

American Journal of Obstetrics and Gynecology

24 September 2017

1 reference

24 September 2017

168

1 reference

24 September 2017

1 Pt 1

1 reference

24 September 2017

214-227

1 reference

Early detection of preeclampsia

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Anti-vascular endothelial cell antibodies in severe preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

The factor VIII ratio in normal and pathological pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Placental-type plasminogen activator inhibitor in preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Prostacyclin and thromboxane in gynecology and obstetrics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Thromboxane A2 synthesis in pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Free-Radical Oxidation (Peroxidation) Products in Plasma in Normal and Abnormal Pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Role of endothelium-derived nitric oxide in the regulation of blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

The action of nitric oxide in the perfused human fetal-placental circulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Platelets and the beginnings of preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Perinatal mortality and birth-weight in relation to aspirin taken during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Mechanisms of action: aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin enhances the sensitivity of human platelet 12-lipoxygenase to inhibition by 15-HETE, an endogenous regulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Increased blood fibrinolytic activity after aspirin ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

PHARMACOLOGY OF ANTIPLATELET DRUGS AND CLINICAL TRIALS ON THROMBOSIS PREVENTION: A DIFFICULT LINK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Absorption kinetics of aspirin in man following oral administration of an aqueous solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin to improve perinatal outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Maternal effects of regular salicylate ingestion in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin and congenital malformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin and maternal or neonatal hemostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Clinical study of the labour inhibiting effects an side effects of acetylsalicylic acid (ASA) (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Congestive heart failure from suspected ductal closure in utero.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Associations Between Oral Clefts and Drugs Taken During Pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Cyclopia and maternal ingestion of salicylates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

A study of angiotensin II pressor response throughout primigravid pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effect of Prostaglandin Synthetase Inhibitors on Pressor Response to Angiotensin II in Human Pregnancy*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effect of aspirin on incidence of pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Prevention of pre-eclampsia by early antiplatelet therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Effect of Low-Dose Aspirin on Fetal and Maternal Generation of Thromboxane by Platelets in Women at Risk for Ppregnancy-Induced Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Aspirin for the treatment of recurrent toxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin does not influence the clinical course of women with mild pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Low-dose aspirin and twin pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

Utilization of over-the-counter drugs during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2812%2990917-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9378(12)90917-5

1 reference

24 September 2017

1 reference

PubMed ID

8420330